CRNA raises NOK 620 million, funding through 2030
CRNA raised NOK 620 million to fund circVec R&D and business development through 2030. The company cites circVec technology advances, including up to 60x improved in-vivo gene expression.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
CRNA raises NOK 620 million for growth through 2030
CRNA said circVec technology advances showed up to 60x–200x improved gene expression in vivo and it has 23 collaborations underway. The company raised NOK 620 million to fund expanded gene and cell therapy programs through 2030.